Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells
/in Breast Cancer, Dendritic Cells, International Publications /von 2003-02-15 / J. Immunol. 2003 Feb;170(4):1980-6TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2003-02-15 / J. Immunol. 2003 Feb;170(4):1814-21A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
/in Hepatocellular Carcinoma, International Publications /von 2003-02-06 / Cancer Immunol. Immunother. 2003 Mar;52(3):155-61Dendritic cell therapy of cancer: can it fulfill its promise?
/in Dendritic Cells, International Publications /von 2003-02-01 / Expert Rev Anticancer Ther 2003 Feb;3(1):1-3Intradermal injection of Newcastle disease virus-modified autologous melanoma cell lysate and interleukin-2 for adjuvant treatment of melanoma patients with resectable stage III disease
/in International Publications, Malignant Melanoma /von 2003-02-01 / J Dtsch Dermatol Ges 2003 Feb;1(2):120-5Fusions of breast cancer and dendritic cells as a novel cancer vaccine
/in Breast Cancer, Dendritic Cells, International Publications /von 2003-02-01 / Clin. Breast Cancer 2003 Feb;3 Suppl 4:S158-63HER2 dendritic cell vaccines
/in Breast Cancer, Dendritic Cells, International Publications /von 2003-02-01 / Clin Breast Cancer 2003 Feb;3 Suppl 4:S164-72Dendritic cell vaccination and viral infection–animal models
/in Chronic Virus Hepatitis, International Publications /von 2003-01-01 / Curr. Top. Microbiol. Immunol. 2003;276:199-214The first 1000 dendritic cell vaccinees
/in Dendritic Cells, International Publications /von 2003-01-01 / Cancer Invest. 2003;21(6):873-86IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de